Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-98-000377
Filing Date
1998-11-17
Accepted
1998-11-17 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G SC 13G 11088
  Complete submission text file 0000947871-98-000377.txt   13026
Mailing Address 9880 CAMPUS POINT DRIVE SANSAN DIEGO CA 92121
Business Address 9880 CAMPUS POINT DRIVE SAN DIEGO CA 92121 6194106500
TREGA BIOSCIENCES INC (Subject) CIK: 0000887920 (see all company filings)

EIN.: 510336233 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45713 | Film No.: 98754230
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND V8
Business Address SCHWARZWALDALLEE 215 4002 BASEL SWITZERLAND 2128302413
NOVARTIS INC (Filed by) CIK: 0001030617 (see all company filings)